ResearchMoz

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

Transparency Market Research
Published Date » 2012-10-08
No. Of Pages » 130
   
 This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report segregates the infertility drugs and devices industry in terms of products, technology and geography. We have used a combination of primary and secondary research to arrive at the market estimates, market shares and trends. We have adopted bottom up model to derive market size of the global infertility drugs and devices market and further validated numbers with the key market participants and C-level executives.  
   
  This report highlights...
TABLE OF CONTENTS

CHAPTER 1 PREFACE
1.1 KEY POINTS COVERED
1.2 REPORT DESCRIPTION
1.3 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY AND MARKET OVERVIEW

CHAPTER 3 INFERTILITY DRUGS AND DEVICES MARKET ANALYSIS
3.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017
3.1.1 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET, 2010 V/S 2017
3.1.2 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017
GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017
3.2 POPULATION GROWTH TREND
3.2.1 GLOBAL MALE AND FEMALE POPULATION GROWTH TREND BY AGE GROUP
3.2.2 INFERTILITY DRUGS AND DEVICES MARKET ATTRACTIVENESS ANALYSIS BY GEOGRAPHY
3.3 CAUSES OF INFERTILITY
3.4 MARKET DYNAMICS
3.4.1 DRIVERS
3.4.1.1 Rising number of infertile people
3.4.1.2 Increasing worldwide obesity
3.4.1.3 Rising disposable incomes of the consumers
3.4.1.4 Lifestyle hazards such as rising number of smokers, stress and pollution
3.4.1.5 Adoption of babies by homosexual couples
3.4.1.6 Availability of government support for infertility abatement procedures
3.4.2 INFERTILITY DRUGS AND DEVICES MARKET DRIVER IMPACT ANALYSIS
3.4.3 RESTRAINTS
3.4.3.1 Limited insurance covers
3.4.3.2 Religious bans on artificial insemination procedures especially the Islamic bans
3.4.3.3 Risk of repeat procedures
3.4.3.4 Traditional infertility treatments such as the Chinese infertility treatments
3.4.3.5 Ban on artificial reproduction procedures in European countries especially Turkey, Germany, Italy and France
3.4.3.6 Patent expiration of infertility drugs
3.4.4 INFERTILITY DRUGS AND DEVICES MARKET RESTRAINTS IMPACT ANALYSIS
3.4.5 OPPORTUNITY
3.4.5.1 Technological advancements in the Asia Pacific region and the developmental activities in the region
3.4.5.2 Medical tourism initiatives in the developing countries
3.4.5.3 Need for more ART cycles
3.1 MARKET SHARE ANALYSIS, 2011
3.2 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET
3.2.1 BARGAINING POWER OF SUPPLIERS
3.2.1 BARGAINING POWER OF BUYERS
3.2.2 THREAT OF NEW ENTRANTS
3.2.3 THREAT OF SUBSTITUTES
3.2.4 COMPETITIVE RIVALRY

CHAPTER 4 INFERTILITY DRUGS AND DEVICES MARKET SEGMENTATION
4.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY TYPES
4.1.1 FEMALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.1.1 Global Infertility drugs and devices market by Endometriosis female infertility types
4.1.1.2 Global Infertility drugs and devices market by Ovarian disorder female infertility types
4.1.1.3 Global Infertility drugs and devices market by Uterine disorder female infertility types
4.1.1.4 Global Infertility drugs and devices market by Tubal disorder female infertility types
4.1.1.5 Global Infertility drugs and devices market by Hormonal disorder female infertility types
4.1.2 MALE INFERTILITY POPULATION PREVALENCE BY TYPES
4.1.2.1 Global Infertility drugs and devices market by Azoospermia male infertility types
4.1.2.2 Global Infertility drugs and devices market by Varicocele male infertility types
4.1.2.3 Global Infertility drugs and devices market by Ejaculation Disorder male infertility types
4.1.2.4 Global Infertility drugs and devices market by Erectile Dysfunction male infertility types
4.2 INFERTILITY DRUGS AND DEVICES MARKET BY TECHNOLOGY
4.2.1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION
4.2.2 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ASSISTED REPRODUCTIVE TECHNOLOGIES (USD THOUSAND) 
4.2.3 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY IN VITRO FERTILIZATION (USD THOUSAND) 
4.2.4 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY SURGERY (USD THOUSAND) 57

CHAPTER 5 REGION-WISE ANALYSIS
5.1 INFERTILITY DRUGS AND DEVICES MARKET BY REGION
5.1.1 EUROPE INFERTILITY DRUGS AND DEVICES MARKET
5.1.1.1 U.K
5.1.1.2 France
5.1.1.3 Germany
5.1.1.4 Italy
5.1.1.5 Spain
5.1.2 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET
5.1.3.1 U.S
5.1.3.2 CANADA
5.1.3.3 MEXICO
5.1.4 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET
5.1.5.1 Japan
5.1.5.2 India
5.1.5.3 China
5.1.6 ROW INFERTILITY DRUGS AND DEVICES MARKET
5.1.7 ROW INFERTILITY DRUGS AND DEVICES MARKET
  5.1.7.1 Brazil’s Infertility drugs and devices market

CHAPTER 6 COMPANY PROFILES
6.1 JOHNSON & JOHNSON
6.1.1 COMPANY OVERVIEW
6.1.2 FINANCIAL OVERVIEW
6.1.3 BUSINESS STRATEGIES
6.1.4 RECENT DEVELOPMENTS
6.2 MERCK
6.2.1 COMPANY OVERVIEW
6.2.2 FINANCIAL OVERVIEW
6.2.3 BUSINESS STRATEGIES
6.2.4 PRODUCT PORTFOLIO
6.2.5 RECENT DEVELOPMENT
6.3 TEVA PHARMACEUTICALS
6.3.1 COMPANY OVERVIEW
6.3.2 FINANCIAL OVERVIEW
6.3.3 BUSINESS STRATEGIES
6.3.4 PRODUCT PORTFOLIO
6.3.5 RECENT DEVELOPMENTS
6.4 ORIGIO
6.4.1 COMPANY OVERVIEW
6.4.2 FINANCIAL OVERVIEW
6.4.3 BUSINESS STRATEGIES
6.4.4 PRODUCT PORTFOLIO
6.4.5 RECENT DEVELOPMENTS
6.5 BAYER
6.5.1 COMPANY OVERVIEW
6.5.2 FINANCIAL OVERVIEW
6.5.3 BUSINESS STRATEGIES
6.5.4 PRODUCT PORTFOLIO
6.5.5 RECENT DEVELOPMENT

List of Tables

LIST OF TABLES

TABLE 1 IMPACT ANALYSIS OF DRIVERS
TABLE 2 IMPACT ANALYSIS OF RESTRAINTS
TABLE 3 GLOBAL FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 4 GLOBAL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 5 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 6 U.K  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 7 U.K POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 8 U.K MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 9 U.K FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 10 U.K INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 11 U.K INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 12 FRANCE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 13 FRANCE POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 14 FRANCE MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 15 FRANCE FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 16 FRANCE INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 17 FRANCE INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 18 GERMANY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 19 GERMANY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 20 GERMANY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 21 GERMANY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 22 GERMANY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND 
TABLE 23 GERMANY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 24 ITALY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 25 ITALY POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 26 ITALY MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 27 ITALY FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 28 ITALY INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 29 ITALY INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 30 SPAIN INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 31 SPAIN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 32 SPAIN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 33 SPAIN FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND ) 
TABLE 34 SPAIN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 35 SPAIN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 36 U.S INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 37 U.S POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 38 U.S MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 39 U.S MALE INFERTILITY POPULATION TREATED, 2010 - 2017 (THOUSAND) 
TABLE 40 U.S FEMALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 41 U.S INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 42 U.S INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 43 CANADA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 44 CANADA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 45 CANADA MALE INFERTILITY POPULATION PREVALENCE 2010 - 2017 (THOUSAND) 
TABLE 46 CANADA FEMALE INFERTILITY POPULATION PREVALENCE, 2010 – 2017 (THOUSAND) 
TABLE 47 CANADA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 48 CANADA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 49 MEXICO INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 50 MEXICO POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 51 MEXICO MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 52 MEXICO FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 53 MEXICO INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 54 MEXICO INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 55 JAPAN  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 56 JAPAN POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 57 JAPAN MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 58 JAPAN FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (MILLION) 
TABLE 59 JAPAN INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 60 JAPAN INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD MILLION) 
TABLE 61 INDIA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 62 INDIA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 63 INDIA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND
TABLE 64 INDIA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND) 
TABLE 65 INDIA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 66 INDIA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND) 
TABLE 67 CHINA  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 68 CHINA POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 69 CHINA MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 70 CHINA FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 71 CHINA INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 72 CHINA INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 73 ROW  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 74 ROW FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 75 ROW INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 
TABLE 76 BRAZIL  INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND) 
TABLE 77 BRAZIL POPULATION BY DEMOGRAPHICS, 2010 - 2017 (THOUSAND) 
TABLE 78 BRAZIL MALE INFERTILITY POPULATION PREVALENCE, 2010 - 2017 (THOUSAND) 
TABLE 79 BRAZIL FEMALE INFERTILITY POPULATION PREVALENCE AND TREATED, 2010 - 2017 (THOUSAND ) 
TABLE 80 BRAZIL INFERTILITY DRUGS AND DEVICES TECHNOLOGY MARKET REVENUE BY FERTILITY TYPE, 2010 – 2017 (USD THOUSAND ) 
TABLE 81 BRAZIL INFERTILITY DRUGS AND DEVICES MARKET BY ARTIFICIAL INSEMINATION TECHNOLOGY, 2010 – 2017 (USD THOUSAND ) 

List of Figures

LIST OF FIGURES

FIG. 1 GLOBAL INFERTILITY DRUGS AND DEVICES MARKET REVENUE (USD THOUSAND) AND ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL INFERTILITY DRUGS AND DEVICES MARKET SHARE, 2010 VS 2017 
FIG. 3 GLOBAL INFERTILITY DRUGS MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 4 GLOBAL POPULATION TREND, MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 5 GLOBAL FERTILE MALE AND FEMALE POPULATION TREND, 2010 – 2017 (THOUSANDS) 
FIG. 6 GLOBAL INFERTILITY DEVICES MARKET REVENUE, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 7 MARKET ATTRACTIVENESS - INFERTILITY DRUGS AND DEVICES MARKET BY GEOGRAPHY 
FIG. 8 CAUSES OF INFERTILITY 
FIG. 9 PORTER’S FIVE FORCES ANALYSIS FOR THE INFERTILITY DRUGS AND DEVICES MARKET 
FIG. 10 COMPARITIVE ANALYSIS OF INFERTILITY DRUGS AND DEVICES MARKET SHARE BY GEOGRAPHY, 2010 AND 2017 (%) 
FIG. 11 EUROPE INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 12 NORTH AMERICA INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 13 ASIA PACIFIC INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 14 DECLINING FERTILITY RATE IN JAPAN, 2007 - 2011 
FIG. 15 ROW INFERTILITY INFERTILITY DRUGS AND DEVICES MARKET, 2010 – 2017 (USD THOUSAND), ANNUAL GROWTH RATE, 2010 – 2017 (%) 
FIG. 16 JOHNSON & JOHNSON’S ANNUAL SALES, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 – 2010 (%) 
FIG. 17 MERCK’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 18 TEVA PHARMACEUTICAL’S ANNUAL REVENUE, 2007 – 2011 (USD MILLION), ANNUAL GROWTH RATE, 2007 - 2010 (%) 
FIG. 19 ORIGIO’S ANNUAL REVENUE, 2010 – 2011 (USD MILLION) 
FIG. 20 BAYER’S ANNUAL SALES, 2010 – 2011 (USD MILLION) 

Upcoming Reports:

Polyphenylene Sulfide Market - Global Industry Analysis, Size, Share, Trends And Forecast 2013 - 2019
By - Transparency Market Research
Polyphenylene sulfide is a polymer that is organic in nature and mainly consists of the aromatic rings which are linked with sulfides. The synthetic fibers manufactured from polyphenylene sulfide are known to offer high resistance to the thermal and chemical attacks. Polyphenylene sulfide is a crystallized thermoplastic polymer that exhibits characteristics such as excellent chemical resistance, high heat deflection temperature, flame retardance and outstanding dimensional stability. Polyphenylene sulfide is also known for its continuous service temperature which mainly ranges from 1800C...
KIOSK Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
By - Transparency Market Research
A kiosk or an electronic kiosk has a built-in computer terminal that employs software coded to function while simultaneously preventing unauthorized users from accessing the system functions. Computerized kiosks store their data locally or retrieve it from a local computer network. Some computer kiosks provide a free public service providing important information while others serve a commercial purpose. They are used as industrial appliances, eliminating paper, improving efficiency and service. There are different types of kiosks depending upon the applications such as: ATM and...
Haemophilus Infections Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020
By - Transparency Market Research
Haemophilus is a group of bacteria that causes different types of illness such as breathing, bone and joint disorders and nervous system disorders. Among all the strains of Haemophilus, H infleunzae type b (Hib) is one of the most common types of infecton causing bacteria. The bacteria is also known as Bacillus Influenzae of Pfeiffer’s bacillus and it is a gram negative, facultatively, ccobacillary, anaerobic bacteria. This strain of bacterium belongs to the Pasteurellaceae family and was first isolated in 1892 during influenza pandemic. Some strains of the H. infleunzae posses a...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Under Armour Makes US$475 Million Deal for MyFitnessPal
Feb 26, 2015  
Baltimore based Under Armour has made earnest attempts in becoming one of the largest players in the fitness apparel market. In their latest venture, the company bought out MyFitnessPal for US$475 million on February 4, 2015. The company also purchased a smaller running app Endomondo for US$85 million. MyFitnessPal is a free fitness app that allows a user to keep a track of his/her...
Hanesbrands Buys Out Knights Apparel
Feb 26, 2015  
Hanesbrands Inc., a leading apparel retailer, has signed an agreement that will allow it to take over Knights Apparel for US$200 million in cash. The latter is a collegiate logo apparel seller. Analysts believe that the acquisition is a strategic one that will provide the right fit to the parent company. White Knights Apparel sells sweatshirts, T-shirts, and other sports apparel with...
Smartphone Market in India on Decline while Samsung Holds Top Spot
Feb 26, 2015  
Korean consumer electronics giant Samsung maintained its leadership in the India smartphone market. The company recorded a 22 per cent share in Q4 of 2014. The overall market has however, shrunk for the first time in history. Most manufacturers of smartphones have had a pileup of inventories in the October to December period, as said by IDC, a market research firm. The firm said that...
Apple to Face over $500 million Payout on iTunes Patent
Feb 26, 2015  
Recently, Apple was accused of using inventions knowingly which were owned by another business in iTunes. The tech giant suffered a patent loss which involved some of these technologies that were used by the iTunes store. As a result the company has been ordered to pay a fine of US$533 million to the company Smartfish. Smartfish is a company which is based in British Virgin Islands and...
Record Connection Speed Achieved by 5G Researchers
Feb 26, 2015  
A record breaking speed has been managed during the test of 5G data connection, according to scientists. The scientists at the University of Surrey’s for 5G Innovation Center or 5GIC were able to achieve a connection speed of 1 tera bit per second, which is thousands of times faster than current data connections. The head of the center at 5GIC stated that he hoped to...